Stephan Reynier
Fortune : 113 535 $ au 31/08/2026
Fortune : 113 535 $ au 31/08/2026
Stephan Reynier currently works at Cellectis SA, as Chief Regulatory & Compliance Officer from 2011.
Mr. Reynier also formerly worked at Gilead Sciences, Inc., as Associate Medical Affairs Director-European Region from 2002 to 2006, Voisin Consulting, Inc., as Senior Director, Takara Bio Europe AB, as Head-Project Management & Regulatory Affairs, and Ectycell SASU, as Head-Programs from 2011 to 2014.
Mr. Reynier received his graduate degree from the University of Toronto.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CELLECTIS S.A. 0,05 % | 15/02/2026 | 33 313 ( 0,05 % ) | 113 535 $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CELLECTIS S.A. | Compliance Officer | 01/04/2011 |
| Sociétés | Poste | Fin |
|---|---|---|
Ectycell SASU
Ectycell SASU BiotechnologyHealth Technology Produces and sales stem cells | Corporate Officer/Principal | 01/01/2014 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/06/2006 |
Voisin Consulting, Inc.
Voisin Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Provides product development consulting services | Directeur/Membre du Conseil | - |
Takara Bio Europe AB
Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Develops hepatocytes and cardiomyocytes from the proprietary stem cells | Conseiller Juridique Général | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 6 |
|---|---|
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cellectis SA
Cellectis SA Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops immunotherapies | Health Technology |
Takara Bio Europe AB
Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Develops hepatocytes and cardiomyocytes from the proprietary stem cells | Commercial Services |
Ectycell SASU
Ectycell SASU BiotechnologyHealth Technology Produces and sales stem cells | Health Technology |
Voisin Consulting, Inc.
Voisin Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Provides product development consulting services | Commercial Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national